Lidocaine

利多卡因

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NameLidocaine
Drug Alias Name利卡多因LidocainumLignocaine利度卡因Lidocain +[17] 
ClassificationSmall molecules
Mechanisms of ActionSodium channel alpha subunit modulators
TargetsSodium channel alpha subunit
Therapy Area/IndicationsSedationContraceptionIschemic Stroke +[77] 
Global Approved IndicationsTachycardia, VentricularHyperemesis GravidarumNeuralgia, Postherpetic +[4] 
Approved Indications in ChinaTachycardia, VentricularHyperemesis Gravidarum
Original Approved Country/TerritoryN/A
Original Approved Date1947/01/01
Country/TerritoryBelgiumCanadaUnited States +[28] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesOmeza LlcNorth Eastern Indira Gandhi Regional Institute Of Health And Medical Sciences (Neigrihms)Armed Forces Institute Of Dentistry, Pakistan +[41] 
Inactive CompaniesUtah State UniversityFederal University Of Sao PauloUniversity of Texas Southwestern Medical Center +[30] 
Active IndicationsContraceptionHumeral FracturesOpioid-Related Disorders +[48] 
Inactive IndicationsSedationIschemic StrokeMenopausal symptoms +[29] 

Other Information

ATC CodeC01BB01C05AD01D04AB01 +[7] 
Related LinksWikipediaDrugBankKEGG